{"organizations": [], "uuid": "202ace0131d0c465e5f852a028c32a22a01c68cc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180114.html", "section_title": "Archive News &amp; Video for Sunday, 14 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shanxi-cy-pharmaceutical-group-uni/brief-shanxi-cy-pharmaceutical-group-units-obtain-high-tech-enterprise-recognition-again-and-to-enjoy-tax-preference-idUSL3N1PA1KS", "country": "US", "domain_rank": 408, "title": "BRIEF-Shanxi C&Y Pharmaceutical Group units obtain high-tech enterprise recognition again and to enjoy tax preference", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.647, "site_type": "news", "published": "2018-01-15T10:51:00.000+02:00", "replies_count": 0, "uuid": "202ace0131d0c465e5f852a028c32a22a01c68cc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shanxi-cy-pharmaceutical-group-uni/brief-shanxi-cy-pharmaceutical-group-units-obtain-high-tech-enterprise-recognition-again-and-to-enjoy-tax-preference-idUSL3N1PA1KS", "ord_in_thread": 0, "title": "BRIEF-Shanxi C&Y Pharmaceutical Group units obtain high-tech enterprise recognition again and to enjoy tax preference", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "c&y pharmaceutical group", "sentiment": "negative"}, {"name": "shanxi c&y pharmaceutical group co ltd", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 15 (Reuters) - Shanxi C&Y Pharmaceutical Group Co Ltd\n* Says Hangzhou-based pharmaceutical unit and tech unit obtained high-tech enterprise recognition again and will enjoy tax preference of 15 percent, for three years\nSource text in Chinese: goo.gl/rVndCm\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/rVndCm"], "published": "2018-01-15T10:51:00.000+02:00", "crawled": "2018-01-15T16:50:47.010+02:00", "highlightTitle": ""}